Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) Non Operating Investment Income (2020 - 2024)

Historic Non Operating Investment Income for IM Cannabis (IMCC) over the last 5 years, with Q3 2024 value amounting to -$16127.2.

  • IM Cannabis' Non Operating Investment Income rose 7675.25% to -$16127.2 in Q3 2024 from the same period last year, while for Sep 2024 it was -$235778.1, marking a year-over-year increase of 6457.59%. This contributed to the annual value of -$729307.6 for FY2023, which is 5546.36% up from last year.
  • Latest data reveals that IM Cannabis reported Non Operating Investment Income of -$16127.2 as of Q3 2024, which was up 7675.25% from -$10967.1 recorded in Q2 2024.
  • IM Cannabis' 5-year Non Operating Investment Income high stood at $3.0 million for Q1 2020, and its period low was -$1.8 million during Q4 2020.
  • Moreover, its 5-year median value for Non Operating Investment Income was -$138500.2 (2022), whereas its average is -$190045.6.
  • In the last 5 years, IM Cannabis' Non Operating Investment Income tumbled by 1184504.97% in 2021 and then skyrocketed by 9704.05% in 2024.
  • IM Cannabis' Non Operating Investment Income (Quarter) stood at -$1.8 million in 2020, then skyrocketed by 95.47% to -$79333.6 in 2021, then crashed by 74.58% to -$138500.2 in 2022, then tumbled by 45.32% to -$201262.7 in 2023, then soared by 91.99% to -$16127.2 in 2024.
  • Its Non Operating Investment Income stands at -$16127.2 for Q3 2024, versus -$10967.1 for Q2 2024 and -$7421.1 for Q1 2024.